SELLAS Life Sciences Grou...

NASDAQ: SLS · Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.62
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

SELLAS Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
25.4M 28.4M 13.89M 21.03M 9.15M 18.52M 2.63M 3.97M 13.81M 23.9M 17.13M 21.35M 26.99M 14.25M 21.36M 26.28M 29.92M 28.03M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -184K n/a n/a n/a -152K n/a n/a n/a
Other Long-Term Assets
261K 263K 466K 43K 270K 272K 275K 377K 381K 384K 399K 521K 514K 554K 594K 597K 623K 676K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M n/a n/a 2.24M 282K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.58M n/a n/a 2.42M 3.09M
Other Current Assets
4.05M 100K 100K 325K 103K 1.78M 100K 525K 475K 388K 330K 463K 433K 1.17M 1.44M 1.95M 103K 1.77M
Total Current Assets
29.45M 31.97M 16.33M 24.04M 12.3M 21.5M 3.17M 5.2M 15.58M 26.02M 17.76M 22.61M 28.74M 17.84M 23.04M 28.97M 34.58M 31.43M
Property-Plant & Equipment
683K 806K 925K 513K 633K 747K 858K 592K 690K 784K 874K 961K 1.04M 1.13M 723K 767K 812K 854K
Goodwill & Intangibles
1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 1.91M 7.61M 7.61M 7.61M
Total Long-Term Assets
2.86M 2.98M 3.31M 2.47M 2.82M 2.93M 3.23M 2.88M 2.98M 3.08M 3.19M 3.4M 3.47M 3.6M 3.23M 8.98M 9.05M 9.14M
Total Assets
32.3M 34.96M 19.43M 26.5M 15.12M 24.43M 6.4M 8.09M 18.57M 29.1M 20.94M 26M 32.21M 21.43M 26.27M 37.95M 43.62M 40.58M
Account Payables
3.34M 3.76M 3.5M 4.55M 6.33M 7.41M 5.64M 4.34M 3.73M 3.1M 3.36M 2.13M 3.34M 2.84M 2.14M 2.54M 2.28M 2.35M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 9.16M n/a n/a n/a n/a n/a 2.48M 2.3M 1.53M 900K
Short-Term Debt
580K n/a n/a n/a 531K 488K 446K 466K 447K 427K n/a 356K 341K 325K 198K 190K 182K 174K
Other Current Liabilities
5.42M 653K 1.82M 1.96M 2.92M -436K -404K -252K 746K 10.94M 5.5M 8.49M 7.3M 6.74M 952K 956K 644K 1.98M
Total Current Liabilities
6M 6.89M 9.51M 10.61M 12.04M 14.44M 13.73M 11.73M 13.42M 15.51M 15.52M 12.55M 12.19M 10.68M 4.98M 5.32M 4.24M 5.97M
Long-Term Debt
157K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a 2K 4K 171K 184K 5.85M 336K 5.12M 5.01M 4.85M
Total Long-Term Liabilities
157K 309K 457K n/a 161K 313K 460K 178K 302K 424K 577K 851K 967K 6.73M 946K 6.03M 5.97M 5.86M
Total Liabilities
6.16M 7.2M 9.97M 10.61M 12.21M 14.75M 14.38M 11.91M 13.72M 15.94M 16.09M 13.4M 13.15M 17.41M 5.93M 11.35M 10.21M 11.83M
Total Debt
737K 870K 1M 576K 692K 801K 906K 644K 749K 849K 945K 1.04M 1.12M 1.21M 808K 857K 903K 949K
Common Stock
10K 9K 7K 6K 5K 5K 3K 3K 3K 3K 2K 2K 2K 2K 2K 2K 2K 2K
Retained Earnings
-260.54M -253.94M -248.13M -241.39M -234.28M -226.81M -217.24M -209.11M -199.84M -191M -179.9M -170.78M -163.76M -155.35M -138.6M -132M -124.92M -120.31M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -0.00 n/a 0.00
Shareholders Equity
26.15M 27.76M 9.46M 15.89M 2.91M 9.68M -7.98M -3.83M 4.84M 13.17M 4.85M 12.6M 19.06M 4.03M 20.35M 26.61M 33.41M 28.74M
Total Investments
n/a n/a n/a 100K n/a n/a n/a n/a n/a n/a -184K n/a n/a n/a -152K n/a n/a n/a